A citation-based method for searching scientific literature

James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski, Pier F Ferrucci, Andrew Hill, John Wagstaff, Matteo S Carlino, John B Haanen, Michele Maio, Ivan Marquez-Rodas, Grant A McArthur, Paolo A Ascierto, Georgina V Long, Margaret K Callahan, Michael A Postow, Kenneth Grossmann, Mario Sznol, Brigitte Dreno, Lars Bastholt, Arvin Yang, Linda M Rollin, Christine Horak, F Stephen Hodi, Jedd D Wolchok. N Engl J Med 2015
Times Cited: 4290



Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe, Mary O'Brien, Suman Rao, Katsuyuki Hotta, Melanie A Leiby, Gregory M Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R Brahmer. N Engl J Med 2016
Times Cited: 4612




List of shared articles



Times cited

Safety of current immune checkpoint inhibitors in non-small cell lung cancer.
Pamela Abdayem, David Planchard. Expert Opin Drug Saf 2021
0

Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
Yuqian Feng, Huimin Jin, Kaibo Guo, Yuying Xiang, Yiting Zhang, Wurong Du, Minhe Shen, Shanming Ruan. Front Pharmacol 2021
1

Neurological complications of immune checkpoint inhibitor cancer immunotherapy.
Cecilia Zivelonghi, Anastasia Zekeridou. J Neurol Sci 2021
0


Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer.
Salomon M Manz, Marco Losa, Ralph Fritsch, Michael Scharl. Therap Adv Gastroenterol 2021
1

A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
Qian Yan, Wenjiang Zheng, Boqing Wang, Baoqian Ye, Huiyan Luo, Xinqian Yang, Ping Zhang, Xiongwen Wang. BioData Min 2021
0

Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis.
Hiroshi Imaoka, Mitsuhito Sasaki, Yusuke Hashimoto, Kazuo Watanabe, Shoichi Miyazawa, Taro Shibuki, Shuichi Mitsunaga, Masafumi Ikeda. Diagnostics (Basel) 2021
0

Palliative care physicians' recognition of patients after immune checkpoint inhibitors and immune-related adverse events.
Yuko Usui, Tomofumi Miura, Takashi Kawaguchi, Kazuhiro Kosugi, Yuko Uehara, Masashi Kato, Toshifumi Kosugi, Miyuki Sone, Naoki Nakamura, Akio Mizushima,[...]. Support Care Cancer 2021
0


Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
Yuan Wei, Xiao Xiao, Xiang-Ming Lao, Limin Zheng, Dong-Ming Kuang. Cell Mol Life Sci 2021
1

Emerging Immunotherapies in the Treatment of Brain Metastases.
Edwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, Ryan J Sullivan, Priscilla K Brastianos. Oncologist 2021
4

Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art.
Olivia Le Saux, Yasmine Lounici, Pauline Wajda, Sarah Barrin, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard. Crit Rev Oncol Hematol 2021
2

The Multiple Potential Biomarkers for Predicting Immunotherapy Response-Finding the Needle in the Haystack.
Tamiem Adam, Therese M Becker, Wei Chua, Victoria Bray, Tara L Roberts. Cancers (Basel) 2021
3


Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma.
Chuanliang Cui, Canqiang Xu, Wenxian Yang, Zhihong Chi, Xinan Sheng, Lu Si, Yihong Xie, Jinyu Yu, Shun Wang, Rongshan Yu,[...]. NPJ Genom Med 2021
5

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.
Tao Ouyang, Yanyan Cao, Xuefeng Kan, Lei Chen, Yanqiao Ren, Tao Sun, Liangliang Yan, Bin Xiong, Bin Liang, Chuansheng Zheng. Front Oncol 2021
1